Moderation of treatment outcomes by polygenic risk for alcohol‐related traits in placebo‐controlled trials of topiramate

Documenti analoghi

• Multi‐ancestry genome‐wide association study of topiramate's effects on heavy alcohol use
  di: Christal N. Davis, et al.
  Pubblicazione: (2025)
• A Mendelian randomization study of alcohol use and cardiometabolic disease risk in a multi‐ancestry population from the Million Veteran Program
  di: Rachel L. Kember, et al.
  Pubblicazione: (2024)
• Genotype‐by‐sex interaction analyses for alcohol use disorder across biobanks
  di: Hang Zhou, et al.
  Pubblicazione: (2025)
• Welcoming ACER's new Editor
  di: Henry R. Kranzler
  Pubblicazione: (2024)
• High‐ and low‐dose topiramate for the treatment of persons with alcohol use disorder who smoke cigarettes: A randomized control trial
  di: Jason D. Robinson, et al.
  Pubblicazione: (2025)